Editor: Ignasi A. Camòs

Cardiac Resynchronization Therapy: An Established Pacing Therapy for Heart Failure and Mechanical Dyssynchrony

eBook: US $22 Special Offer (PDF + Printed Copy): US $91
Printed Copy: US $80
Library License: US $88
ISBN: 978-1-60805-655-2 (Print)
ISBN: 978-1-60805-030-7 (Online)
Year of Publication: 2011
DOI: 10.2174/97816080503071110101


In recent decades, the prevalence of heart failure has steadily increased and can be considered a contemporary cardiovascular epidemic. Therefore, treatment of heart failure is a primary focus of cardiovascular disease management strategies. Cardiac resynchronization therapy: an established pacing therapy for heart failure and mechanical dyssynchrony provides basic knowledge about congestive heart failure and also covers the evolution of cardiac resynchronization therapy. State-of-the-art information and future directions of this therapeutic tool are explained. As cardiac resynchronization therapy (CRT) is a new therapy which still undergoes rapid advancement, it is imperative to provide updates on key issues. These include technological advances, the unique role of imaging to assess mechanical dyssynchrony, troubleshooting, recent key clinical trials, and the incorporation of monitoring capabilities into CRT or CRT plus defibrillation devices. Cardiac resynchronization therapy is an exciting new option for a growing number of heart failure patients, but CRT systems present special challenges to clinicians, even those accustomed to working with pacemakers.


In the last two decades we have witnessed major advances in our therapeutic options to treat heart failure. Among them, cardiac resynchronization therapy (CRT) has emerged as a standard of care for patients with congestive heart failure, depressed left ventricular ejection fraction and ventricular dyssynchrony.

“Cardiac Resynchronization Therapy: An Established Pacing Therapy for Heart Failure and Mechanical Dyssynchrony” has been written by a broad panel of experts in the field that was selected on their leadership in heart failure, electrophysiology, echocardiography and CRT. The book starts with an excellent update on the pathophysiology and clinical significance of cardiac dyssynchrony, very useful not only for heart failure specialists, but also for the general clinical cardiologist. The role of echocardiography for the evaluation of dyssynchrony and for the follow-up of the device is easy and friendly approached in two chapters. Finally, the role of CRT in new indications such as NYHA class II patients or right bundle branch block is comprehensively addressed in the last part of the book.

Anguera´s book is intended to be very clinically oriented. Particularly, the part of programming and follow-up is enriched with clinical cases to illustrate the theoretical basis of CRT. Indeed, most clinicians will find this excellent book of immediate practical use. Personally I consider it an exciting contribution for anyone interested in CRT.

Ignacio Garcia Bolao,MD
Department of Cardiology and Cardiac Surgery
University Clinic of Navarre, Pamplona


.Advancements in Cardiovascular Research and Therapeutics: Molecular and Nutraceutical Perspectives.
.Blood Oxidant Ties: The Evolving Concepts in Myocardial Injury and Cardiovascular Disease.
.Cardiac Care and COVID-19: Perspectives in Medical Practice.
.Nanomedicinal Approaches Towards Cardiovascular Disease.